Financial reports
10-K
2023 FY
Annual report
12 Mar 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
10 Mar 22
Current reports
8-K
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
12 Mar 24
8-K
Departure of Directors or Certain Officers
28 Feb 24
8-K
Other Events
25 Jan 24
8-K
Departure of Directors or Certain Officers
22 Nov 23
8-K
Departure of Directors or Certain Officers
15 Nov 23
8-K
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results
2 Nov 23
8-K
Entry into a Material Definitive Agreement
25 Oct 23
8-K
Other Events
18 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Sep 23
8-K
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
3 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
12 Mar 24
SC TO-I/A
Issuer tender offer statement (amended)
28 Feb 24
SC TO-I
Issuer tender offer statement
30 Jan 24
SC TO-C
Information about tender offer
25 Jan 24
424B3
Prospectus supplement
28 Nov 23
S-3
Shelf registration
17 Nov 23
D
$92.15 mm in equity / options / securities to be acquired, sold $92.15 mm, 11 investors
7 Nov 23
S-8
Registration of securities for employees
9 Mar 23
S-8
Registration of securities for employees
10 Mar 22
S-3
Shelf registration
4 Nov 21
Proxies
PRE 14A
Preliminary proxy
16 Apr 24
DEFR14A
Revised proxy
2 Jun 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
Other
EFFECT
Notice of effectiveness
28 Nov 23
CORRESP
Correspondence with SEC
22 Nov 23
UPLOAD
Letter from SEC
21 Nov 23
UPLOAD
Letter from SEC
27 Dec 22
CORRESP
Correspondence with SEC
22 Dec 22
UPLOAD
Letter from SEC
8 Dec 22
EFFECT
Notice of effectiveness
22 Nov 21
CORRESP
Correspondence with SEC
17 Nov 21
UPLOAD
Letter from SEC
15 Nov 21
EFFECT
Notice of effectiveness
1 Jul 21